Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Higgins John L
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,806,928    

Indirect Shares

   0      
Direct Value   $47,741,724    

Indirect Value

   $0      
Total Shares   2,806,928      
Total Value   $47,741,724      


Ligand Pharmaceuticals Inc $33,983,665 Techne Corp $2,841,879 OmniAb, Inc $10,916,180 Ligand Pharmaceuticals Inc $33,983,665 Techne Corp $2,841,879 OmniAb, Inc $10,916,180
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    11    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    6    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -36.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Director 2022-12-28 417,695 2007-02-01 0    Premium*  
            Techne Corp TECH Director 2024-05-14 36,608 2013-10-31 0    Premium*  
            OmniAb, Inc OABI Director 2024-01-30 2,352,625 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    165         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2014-01-16 4 AS $64.00 $960,000 D/D (15,000) 102,099 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2014-02-12 4 AS $75.00 $1,265,625 D/D (16,875) 111,099 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-03-20 4 AS $109.10 $436,400 D/D (4,000) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-06-09 4 AS $114.87 $1,378,440 D/D (12,000) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-06-21 4 AS $120.00 $559,920 D/D (4,666) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-08-08 4 AS $125.00 $685,375 D/D (5,483) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-09-05 4 AS $130.00 $650,000 D/D (5,000) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-01-19 4 AS $151.92 $4,318,902 D/D (28,099) 134,200 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-01-24 4 AS $165.00 $3,712,500 D/D (22,500) 111,700 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-02-15 4 AS $157.03 $1,413,279 D/D (9,000) 102,700 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-05-15 4 AS $179.97 $2,232,491 D/D (12,405) 107,419 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-08-16 4 AS $241.33 $5,190,261 D/D (21,507) 88,919 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-08-17 4 AS $243.00 $3,157,299 D/D (12,993) 88,919 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 AS $159.00 $7,950,000 D/D (50,000) 235,310 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-27 4 AS $182.00 $7,280,000 D/D (40,000) 243,422 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-02-05 4 AS $203.40 $11,119,239 D/D (54,666) 286,030 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2022-11-17 4 AS $78.32 $783,173 D/D (10,000) 416,731 0 %
LGND Ligand Pharmaceuticals In... Director   –       •      –    2022-12-16 4 AS $61.87 $618,657 D/D (10,000) 422,984 0 %
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2007-06-15 4 B $6.70 $13,400 D/D 2,000 152,000 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2007-08-13 4 B $5.86 $11,720 D/D 2,000 154,000 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2010-02-17 4 B $1.67 $10,020 D/D 6,000 439,276 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-05-04 4 B $12.04 $12,040 D/D 1,000 108,275 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-08-13 4 B $16.39 $8,195 D/D 500 110,025 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-12-05 4 B $18.03 $36,060 D/D 2,000 112,025 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2014-08-15 4 B $54.97 $54,970 D/D 1,000 120,099 2.81 -
  165  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us